Health and Wealth, en podd från BioStock om investeringar i life science

• Confessions of a business angel – I listen to Bach and review investment cases

  From his childhood venture as a self-employed gardener, to multi-exit entrepreneur and seasoned business angel currently co-raising a 500 MSEK life science fund. Kristofer Klerfalk shares his personal story and insights on being a founder friendly investor, how you review +1000 pitch cases annually (hint: listening to classical music helps!) and the internal checklist he uses to spot a great investment opportunity. Hosted on Acast. See acast.com/privacy for more information.

  --------  

  59:38
• On leadership, breaking new ground and Calliditas billion dollar exit

  A conversation with Calliditas former CEO Renée Aguiar-Lucander on leadership, courage and transitioning from an early career in the male-dominated world of international finance and investment banking, to breaking new ground as a life science leader on a challenging but rewarding journey towards a multi-billion dollar sale of the company. Hosted on Acast. See acast.com/privacy for more information.

  --------  

  59:29
• The best years in venture capital overlap perfectly with big crises

  Søren Lemonius, founder and managing partner at Sunstone Life Science Ventures, shares the story of how he and his team initiated the Danish VC firm’s investment strategy that has lead to a number of very successful exits – and to some very costly losses. He also reveals why early-stage deals often yield the best returns (”because you’re selling a multiple of a dream”), explains why venture capital thrives in times of crisis and shares the one major reason for why some investments never materialise. We ponder the concept of longevity and find out what Søren considers to be the next hot areas to invest in, why IPOs are not a prefered exit option for Sunstone’s investments and why venture capital firms usually thrive in times of crisis. Hosted on Acast. See acast.com/privacy for more information.

  --------  

  1:15:57
• Earthquakes, investing in drugs and how to be decent in Venture Capital

  When Johan Kördel, a seasoned investor and managing partner at Swedish venture capital firm Sound Bioventures, suddenly woke up during an earthquake, he knew exactly what to do, yet he did nothing. Luckily, he lived to tell us the earthquake story, and much more! In this episode of Health & Wealth we talk about the dangers of doing nothing as a leader, the importance of risk management and why a portfolio approach is key when you invest in drug development. We also dive into his best investments (and a truly eye-popping exit!), learn about raising a billion SEK fund during a pandemic (hint: you need skin in the game!) and discuss why some disease areas are not considered lucrative, and why being decent is very cool. Hosted on Acast. See acast.com/privacy for more information.

  --------  

  1:10:10
• Målet: Förändra världen för hundra miljoner

  Drivkraften för Philip Siberg, vd på Senzime, är att göra skillnad i hundra miljoner människors liv. Hör honom berätta om varför han bestämt sig för att arbeta för hållbarhet, mänskliga rättigheter och om vikten att sträva mot en vision som är värd att berätta för barnbarnen om! Hosted on Acast. See acast.com/privacy for more information.

  --------  

  34:20

Fler podcasts i Vetenskap

Trendiga poddar i Vetenskap

Om Health and Wealth, en podd från BioStock om investeringar i life science